Nanoparticle‐Mediated STING Agonist Delivery for Enhanced Cancer Immunotherapy
Authors:
- 12 June 2021
- journal article
- review article
- Published by Wiley in Macromolecular Bioscience
- Vol. 21 (8) , 2100133
Abstract
Stimulator of interferon genes (STING) are located in the endoplasmic reticulum of cells, which have been demonstrated to show considerable potentials to achieve efficient antitumor immunity by inducing various pro‐inflammatory cytokines and chemokines, such as type I interferons. A variety of STING agonists have been prepared for STING activation, and many of them have been promoted to preclinical trials or clinical applications for the immunotherapy of cancers. However, the intrinsic disadvantages of the small molecule STING agonists can limit the in vivo application and final therapeutic efficacy due to low bioavailability of targeting tissues. Moreover, a cascade of physiological barriers for in vivo STING activation also limit the accumulation of STING agonists in targeting tissues. Drug delivery systems play an important role to improve the STING activation efficiency. In recent years, a variety of nanoparticle‐mediated STING agonist delivery systems have been engineered and exploited to address the challenges related to the in vivo STING activation, including liposomes, polymeric micelles, polymersomes, and so on. In this review article, the progresses concerning STING agonists and related delivery systems in recent years will be summarized and discussed.Keywords
This publication has 61 references indexed in Scilit:
- Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon PathwayScience, 2013
- Block copolymer micelles for drug delivery: Design, characterization and biological significanceAdvanced Drug Delivery Reviews, 2012
- Polymersomes for drug delivery: Design, formation and characterizationJournal of Controlled Release, 2012
- Liposomes: From a Clinically Established Drug Delivery System to a Nanoparticle Platform for Theranostic NanomedicineAccounts of Chemical Research, 2011
- STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunityNature, 2009
- Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvantJournal of Experimental Medicine, 2009
- Stimuli‐Responsive Polymersomes as Nanocarriers for Drug and Gene DeliveryMacromolecular Bioscience, 2009
- STING is an endoplasmic reticulum adaptor that facilitates innate immune signallingNature, 2008
- Immunomodulatory Actions of Xanthenone Anticancer AgentsBioDrugs, 1997
- Regulation of cellulose synthesis in Acetobacter xylinum by cyclic diguanylic acidNature, 1987